Annual D&A
$619.70 K
+$22.80 K+3.82%
31 December 2023
Summary:
Silence Therapeutics annual depreciation & amortization is currently $619.70 thousand, with the most recent change of +$22.80 thousand (+3.82%) on 31 December 2023. During the last 3 years, it has fallen by -$16.90 thousand (-2.65%). SLN annual D&A is now -20.78% below its all-time high of $782.30 thousand, reached on 31 December 2008.SLN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$159.10 K
+$9800.00+6.56%
01 September 2024
Summary:
Silence Therapeutics quarterly depreciation & amortization is currently $159.10 thousand, with the most recent change of +$9800.00 (+6.56%) on 01 September 2024. Over the past year, it has dropped by -$2900.00 (-1.79%). SLN quarterly D&A is now -18.62% below its all-time high of $195.50 thousand, reached on 31 December 2022.SLN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$602.90 K
-$2900.00-0.48%
01 September 2024
Summary:
Silence Therapeutics TTM depreciation & amortization is currently $602.90 thousand, with the most recent change of -$2900.00 (-0.48%) on 01 September 2024. Over the past year, it has dropped by -$70.00 thousand (-10.40%). SLN TTM D&A is now -10.40% below its all-time high of $672.90 thousand, reached on 30 September 2023.SLN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.8% | -1.8% | -10.4% |
| 3 y3 years | -2.6% | +8.3% | +21.1% |
| 5 y5 years | +16.4% | - | - |
SLN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.6% | +5.5% | -18.6% | +77.4% | -10.4% | +22.8% |
| 5 y | 5 years | -2.6% | +16.4% | -18.6% | +77.4% | -10.4% | +241.8% |
| alltime | all time | -20.8% | >+9999.0% | -18.6% | +77.4% | -10.4% | +241.8% |
Silence Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $159.10 K(+6.6%) | $602.90 K(-0.5%) |
| June 2024 | - | $149.30 K(-1.9%) | $605.80 K(-0.5%) |
| Mar 2024 | - | $152.20 K(+7.0%) | $609.00 K(-1.7%) |
| Dec 2023 | $619.70 K(+3.8%) | $142.30 K(-12.2%) | $619.70 K(-7.9%) |
| Sept 2023 | - | $162.00 K(+6.2%) | $672.90 K(+7.3%) |
| June 2023 | - | $152.50 K(-6.4%) | $626.90 K(+3.1%) |
| Mar 2023 | - | $162.90 K(-16.7%) | $608.20 K(+1.9%) |
| Dec 2022 | $596.90 K(+1.6%) | $195.50 K(+68.5%) | $596.90 K(+21.5%) |
| Sept 2022 | - | $116.00 K(-13.3%) | $491.10 K(-5.9%) |
| June 2022 | - | $133.80 K(-11.7%) | $522.00 K(-7.2%) |
| Mar 2022 | - | $151.60 K(+69.0%) | $562.60 K(-4.2%) |
| Dec 2021 | $587.40 K(-7.7%) | $89.70 K(-38.9%) | $587.40 K(+18.0%) |
| Sept 2021 | - | $146.90 K(-15.8%) | $497.70 K(+41.9%) |
| June 2021 | - | $174.40 K(-1.1%) | $350.80 K(+98.9%) |
| Mar 2021 | - | $176.40 K | $176.40 K |
| Dec 2020 | $636.60 K(+3.4%) | - | - |
| Dec 2019 | $615.40 K(+15.6%) | - | - |
| Dec 2018 | $532.40 K(-4.8%) | - | - |
| Dec 2017 | $559.10 K(+33.1%) | - | - |
| Dec 2016 | $420.00 K(+51.0%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $278.10 K(-49.2%) | - | - |
| Dec 2014 | $547.30 K(+17.8%) | - | - |
| Dec 2013 | $464.70 K(+16.4%) | - | - |
| Dec 2012 | $399.30 K(-18.4%) | - | - |
| Dec 2011 | $489.10 K(-1.8%) | - | - |
| Dec 2010 | $497.90 K(-14.3%) | - | - |
| Dec 2009 | $581.10 K(-25.7%) | - | - |
| Dec 2008 | $782.30 K(+22.9%) | - | - |
| Dec 2007 | $636.40 K(-2.2%) | - | - |
| Dec 2006 | $650.80 K(+65.6%) | - | - |
| Dec 2005 | $393.00 K(+464.7%) | - | - |
| Dec 2004 | $69.60 K(-3.3%) | - | - |
| Dec 2003 | $72.00 K(-14.5%) | - | - |
| Dec 2002 | $84.20 K(+39.2%) | - | - |
| Dec 2001 | $60.50 K(+37.5%) | - | - |
| Dec 2000 | $44.00 K(+353.6%) | - | - |
| Dec 1999 | $9700.00(-83.8%) | - | - |
| Dec 1998 | $59.70 K(+7.2%) | - | - |
| Dec 1997 | $55.70 K(+4.9%) | - | - |
| Dec 1996 | $53.10 K(+3218.8%) | - | - |
| Dec 1995 | $1600.00 | - | - |
FAQ
- What is Silence Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Silence Therapeutics?
- What is Silence Therapeutics annual D&A year-on-year change?
- What is Silence Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Silence Therapeutics?
- What is Silence Therapeutics quarterly D&A year-on-year change?
- What is Silence Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Silence Therapeutics?
- What is Silence Therapeutics TTM D&A year-on-year change?
What is Silence Therapeutics annual depreciation & amortization?
The current annual D&A of SLN is $619.70 K
What is the all time high annual D&A for Silence Therapeutics?
Silence Therapeutics all-time high annual depreciation & amortization is $782.30 K
What is Silence Therapeutics annual D&A year-on-year change?
Over the past year, SLN annual depreciation & amortization has changed by +$22.80 K (+3.82%)
What is Silence Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of SLN is $159.10 K
What is the all time high quarterly D&A for Silence Therapeutics?
Silence Therapeutics all-time high quarterly depreciation & amortization is $195.50 K
What is Silence Therapeutics quarterly D&A year-on-year change?
Over the past year, SLN quarterly depreciation & amortization has changed by -$2900.00 (-1.79%)
What is Silence Therapeutics TTM depreciation & amortization?
The current TTM D&A of SLN is $602.90 K
What is the all time high TTM D&A for Silence Therapeutics?
Silence Therapeutics all-time high TTM depreciation & amortization is $672.90 K
What is Silence Therapeutics TTM D&A year-on-year change?
Over the past year, SLN TTM depreciation & amortization has changed by -$70.00 K (-10.40%)